Effects of Gestational Diabetes Mellitus on the Offspring's Neurodevelopment.
文献摘要
Gestational diabetes mellitus (GDM) is a major global health concern that affects up to 14% of pregnancies. Traditionally, it has been characterized by hyperglycemia and insulin resistance. However, GDM can also lead to long-term health consequences in offspring, particularly affecting neurodevelopment. It has been associated with an increased risk of cognitive deficits, attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and emotional dysregulation in GDM-exposed offspring. Findings from human and experimental studies suggest that GDM disrupts cortical and hippocampal architecture, impairs synaptic plasticity, and induces epigenetic alterations in key neurodevelopmental genes. These mechanistic pathways include oxidative stress, inflammation, apoptosis, and altered neurotrophin expression and receptor signaling. Maternal metabolism, diet, and genetic background may negatively affect neurotrophin expression, which could impact fetal brain development. Lower levels of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in maternal blood, placental tissue, and cord blood have been linked to poor neurodevelopmental outcomes. This suggests that neurotrophins could be considered potential biomarkers. This narrative review compiles the latest evidence on the effects of GDM on fetal brain development, emphasizing the role of neurotrophins, especially BDNF and NGF, as critical mediators in this process. Emerging data also suggest that glycemic control during pregnancy may partially restore neurotrophin levels and improve neurodevelopmental outcomes. Understanding the interaction between maternal glucose metabolism and fetal brain signaling pathways is essential for pregnancy care and the design of neuroprotective strategies.